Free radical generating organic peroxides and hydroperoxides are known to promote tumors in mouse skin and iron has been shown to participate in free radical generating reactions. In the present study, we have used various peroxides and hydroperoxides as stage-I and -II tumor promoters and have studied the effect of iron-overload on the two stages of tumor promotion. Swiss albino mice were iron-overloaded by injecting iron-dextran (1.0 mg Fe/mouse per day for 15 days). Twenty-four hours after the last injection of iron-dextran, the animals were initiated with 40 microg 7,12 dimethylbenz[a]anthracene. One week following initiation stage-I tumor promotion was accomplished by applying 12-O-tetradecanoyl phorbol-13-acetate (TPA), benzoyl peroxide (BPO), cumene hydroperoxide (COOH) or H(2)O(2) to mice twice weekly for 2 weeks. Stage-II tumor promotion was accomplished by applying mezerein, BPO, COOH or H(2)O(2) to these mice twice weekly for 40 weeks. The appearance of the first papilloma and the number of tumors/mouse were recorded weekly. When compared to non-iron-overloaded mice, the iron-overloaded mice showed a higher tumor incidence and number of tumors/mouse. The order in which iron-overload was effective in increasing tumor promotion by stage-I tumor promoters was H(2)O(2)>COOH>BPO>TPA and the order in which iron-overload was effective in increasing tumor promotion by stage-II tumor promoters was COOH>mezerein>BPO. Induction in ornithine decarboxylase (ODC) activity, [(3)H]thymidine incorporation in cutaneous DNA and cutaneous lipid peroxidation were also higher in the iron-overloaded mice. TPA was the most effective in inducing epidermal ODC activity and [(3)H]thymidine incorporation followed by mezerein, COOH and BPO. In addition, the level of epidermal reduced glutathione and the activities of antioxidant enzymes were lower in iron-overloaded mice. Besides this, cutaneous iron levels were higher in iron-overloaded mice. Thus, we conclude from this study that iron-overload augments stage-I and stage-II of tumor promotion in murine skin.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0304-3835(02)00116-7 | DOI Listing |
Biomacromolecules
January 2025
School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.
Polymer-based photosensitizers have found various applications in photodynamic therapy (PDT). However, the absence of targeting ability commonly results in a substantial reduction in photosensitizer accumulation at the tumor site, significantly limiting the therapeutic efficacy of the system. In addition, the development of biodegradable polymeric photosensitizers is of critical importance for biological applications.
View Article and Find Full Text PDFIntegr Cancer Ther
January 2025
Department of Physical Therapy, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Introduction: Balance problems arising from cancer and its treatments can significantly impact daily functionality and quality of life. Improving balance as part of a cancer treatment plan could result in better patient outcomes. Thus, the aim of this study was to determine whether an integrative therapeutic yoga intervention can improve balance in a heterogenous population of cancer survivors (CS).
View Article and Find Full Text PDFCellular senescence is characterized by a stable cell cycle arrest and a hypersecretory, proinflammatory phenotype in response to various stress stimuli. Traditionally, this state has been viewed as a tumor-suppressing mechanism that prevents the proliferation of damaged cells while activating the immune response for their clearance. However, senescence is increasingly recognized as a contributing factor to tumor progression.
View Article and Find Full Text PDFMol Ther Oncol
March 2025
Early Protein Supply and Characterization, Merck Healthcare KGaA, 64293 Darmstadt, Germany.
In this work, we report the discovery and engineering of allosteric variable domains of the heavy chain (VHHs) derived from camelid immunization targeting NKp30, an activating receptor on natural killer (NK) cells. The aim was to enhance NK cell-mediated killing capacities by identifying VHHs that do not compete with the natural ligand of NKp30:B7-H6, thereby maximizing the recognition of B7-H6 tumor cells. By relying on the DuoBody technology, bispecific therapeutic antibodies were engineered, creating a panel of bispecific antibodies against NKp30xEGFR (cetuximab moiety) or NKp30xHER2 (trastuzumab moiety), called natural killer cell engagers (NKCEs).
View Article and Find Full Text PDFiScience
January 2025
Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA 17033, USA.
ZFAND6 is a zinc finger protein that interacts with TNF receptor-associated factor 2 (TRAF2) and polyubiquitin chains and has been linked to tumor necrosis factor (TNF) signaling. Here, we report a previously undescribed function of ZFAND6 in maintaining mitochondrial homeostasis by promoting mitophagy. Deletion of ZFAND6 in bone marrow-derived macrophages (BMDMs) upregulates reactive oxygen species (ROS) and the accumulation of damaged mitochondria due to impaired mitophagy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!